Ahmad Fawzi Hussain - Concepedia

Author

Ahmad Fawzi Hussain

Fraunhofer Institute for Molecular Biology and Applied Ecology ORCID

Also Known As

A. Hussain, Ahmad F. Hussain, Ahmad Fawzi Hussain, Ahmad Fawzi Hussain Ahmad Fawzi Hussain, Ahmad Hussain, Hussain, A.

Publications

Citations

H-Index

Concepts

All Affiliations

Fraunhofer Institute for Molecular Biology and Applied Ecology University of Cape Town RWTH Aachen University University of Lübeck Justus-Liebig-Universität Gießen

About

Ahmad Fawzi Hussain is an author at Fraunhofer Institute for Molecular Biology and Applied Ecology specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	579
2	Health Sciences	3	3	232
3	Biomedical Engineering	2	2	190
4	Engineering	1	1	63
5	Natural Sciences	1	1	28

Ahmad Fawzi Hussain

Publications

614

Citations

H-Index

Page 1

	Year	Citations
Control of mechanical pain hypersensitivity in mice through ligand-targeted photoablation of TrkB-positive sensory neurons Rahul Dhandapani, Cynthia M. Arokiaraj, Francisco J. Taberner, Nature Communications Pain MedicineLight TouchNeuropathic PainMolecular PainBiomedical Engineering	2018	127
SNAP-Tag Technology Mediates Site Specific Conjugation of Antibody Fragments with a Photosensitizer and Improves Target Specific Phototoxicity in Tumor Cells Ahmad Fawzi Hussain, Florian Kampmeier, Verena von Felbert, Bioconjugate Chemistry ImmunologyAntibody FragmentsTumor CellsSpecific ConjugationImmunotherapy	2011	72
Targeted Delivery of Dendritic Polyglycerol–Doxorubicin Conjugates by scFv-SNAP Fusion Protein Suppresses EGFR<sup>+</sup> Cancer Cell Growth Ahmad Fawzi Hussain, Harald Rune Krüger, Florian Kampmeier, Biomacromolecules Ethylene GlycolEngineeringBiomedical EngineeringTumor BiologyProtein Nanoparticles	2013	63
HER2-low expression in patients with advanced or metastatic solid tumors Burak Uzunparmak, Cara Haymaker, Gabriela Raso, Annals of Oncology Breast OncologyMalignant DiseaseMedicinePathologyHer2-low Expression	2023	63
Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model Manal Amoury, Katharina Kolberg, Anh‐Tuan Pham, Cancer Letters Breast OncologyMedicineImmunologyImmune Checkpoint InhibitorBreast Cancer	2016	43
A specific photoimmunotheranostics agent to detect and eliminate skin cancer cells expressing EGFR Verena von Felbert, Dirk Bauerschlag, Nicolaì Maass, Journal of Cancer Research and Clinical Oncology Specific Photoimmunotheranostics AgentPhotocarcinogenesisImmunologySkin Cancer CellsPhotosensitizers	2016	36
A novel approach for targeted elimination of CSPG4‐positive triple‐negative breast cancer cells using a MAP tau‐based fusion protein Manal Amoury, Radoslav Mladenov, Thomas Nachreiner, International Journal of Cancer Targets Cspg4ImmunologyNovel ApproachImmunotherapeuticsImmunotherapy	2016	34
Photoimmunotheranostic agents for triple-negative breast cancer diagnosis and therapy that can be activated on demand Manal Amoury, Dirk Bauerschlag, Felix Zeppernick, Oncotarget Breast OncologyNanotherapeuticsImmunologyImmunotherapeuticsTnbc Cells	2016	33
One-step site-specific antibody fragment auto-conjugation using SNAP-tag technology Ahmad Fawzi Hussain, Paul A. Heppenstall, Florian Kampmeier, Nature Protocols Snap-tag TechnologyImmunologyAntibody EngineeringProtein EngineeringAntibody Screening	2019	31
An Aptamer–siRNA Chimera Silences the Eukaryotic Elongation Factor 2 Gene and Induces Apoptosis in Cancers Expressing αvβ3 Integrin Ahmad Fawzi Hussain, Mehmet Kemal Tur, Stefan Barth Nucleic Acid Therapeutics Rna AptamersApoptosisImmunologyMolecular BiologyCell Death	2013	28

Page 1